|
⚲
|
| Keyboard |
| Livingston Philip O
✚
|
|
|---|---|
| CIK # | 0001612050 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001612050] | |
| 4 | [0001612050] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Mabvax Therapeutics Holdings Inc | |
| Livingston Philip O |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Mabvax Therapeutics Holdings Inc MBVX
Option to Purchase Common Stock · derivative
|
2018-02-21 | Grant | 35,000 | $0.00 | |
|
Mabvax Therapeutics Holdings Inc MBVX
Common Stock
|
2018-01-12 | Sell | 3,571 | $0.96 | 3,428 |
|
Mabvax Therapeutics Holdings Inc MBVX
Common Stock
|
2018-01-11 | Sell | 12,301 | $0.98 | 12,055 |
|
Mabvax Therapeutics Holdings Inc MBVX
Common Stock
|
2018-01-10 | Sell | 21,155 | $0.96 | 20,309 |
|
Mabvax Therapeutics Holdings Inc MBVX
Restricted Stock Unit · derivative
|
2018-01-08 | Option exercise | 100,000 | ||
|
Mabvax Therapeutics Holdings Inc MBVX
Common Stock
|
2018-01-08 | Option exercise | 100,000 | $0.00 | |
|
Mabvax Therapeutics Holdings Inc MBVX
Restricted Stock Unit · derivative
|
2017-10-02 | Grant | 75,790 | ||
|
Mabvax Therapeutics Holdings Inc MBVX
Restricted Stock Unit · derivative
|
2017-09-15 | Grant | 24,210 | ||
|
Mabvax Therapeutics Holdings Inc MBVX
Option to Purchase Common Stock · derivative
|
2017-05-19 | Grant | 50,000 | $2.00 | 100,000 |
|
Mabvax Therapeutics Holdings Inc MBVX
Option to Purchase Common Stock · derivative
|
2017-01-01 | Grant | 700 | $3.38 | 2,366 |
|
Mabvax Therapeutics Holdings Inc MBVX
Option to Purchase Common Stock · derivative
|
2016-08-29 | Grant | 700 | $5.00 | 3,500 |
|
Mabvax Therapeutics Holdings Inc MBVX
Common Stock
|
2015-04-04 | Grant | 1,000,000 | $0.00 |